1. Home
  2. EVG vs CDXS Comparison

EVG vs CDXS Comparison

Compare EVG & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

EVG

Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

N/A

Current Price

$9.96

Market Cap

136.9M

Sector

Finance

ML Signal

N/A

Logo Codexis Inc.

CDXS

Codexis Inc.

N/A

Current Price

$1.14

Market Cap

154.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
EVG
CDXS
Founded
N/A
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Major Chemicals
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
136.9M
154.4M
IPO Year
2004
2008

Fundamental Metrics

Financial Performance
Metric
EVG
CDXS
Price
$9.96
$1.14
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $6.14
AVG Volume (30 Days)
65.9K
★ 845.5K
Earning Date
01-01-0001
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 43.82
EPS
★ N/A
N/A
Revenue
N/A
★ $138,590,000.00
Revenue This Year
N/A
$5.02
Revenue Next Year
N/A
$18.66
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 32.30
52 Week Low
$9.78
$0.90
52 Week High
$11.25
$2.98

Technical Indicators

Market Signals
Indicator
EVG
CDXS
Relative Strength Index (RSI) 34.80 47.51
Support Level $9.78 $0.96
Resistance Level $10.95 $1.29
Average True Range (ATR) 0.18 0.09
MACD -0.06 -0.00
Stochastic Oscillator 8.28 55.81

Price Performance

Historical Comparison
EVG
CDXS

About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: